fda news - Search News

FDA, Wegovy and Ozempic

CNBC on MSN · 6h

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.

Reuters on MSN · 9h

US FDA says lowest dose of Novo Nordisk's weight-loss drug now available

The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday. Several doses of Novo's GLP-1 therapies such as Wegovy and diabetes drug Ozempic,

Ozempic, Wegovy move closer to no longer being in shortage, FDA says

Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA.

FDA, asbestos and baby powder

ABC 7 Chicago · 2h

FDA expands recall of Dynacare baby powder, sent to IL, IN, WI, due to possible asbestos risk

The Food and Drug administration has expanded a recall of Dynacare baby powder, made by the Dynarex Corporation. The recall expansion is due to recent tests that indicate the possible risk of asbestos. The FDA said the recall is now affecting products in 35 states, up from just 12 states in September.

Scripps News on MSN · 4h

Recall expanded for baby powder that may contain asbestos, FDA says

A recall issued last month for Dynacare brand baby powder over concerns of asbestos contamination has been expanded, the Food and Drug Administration announced Tuesday.

Baby powder removed from shelves nationwide: FDA

You might want to check your baby powder. A nationwide recall has been expanded for Dynacare Baby Powder after the FDA discovered certain batches could be contaminated with asbestos. Asbestos is a dangerous substance that could lead to health problems and increased risk of developing lung cancer and mesothelioma,

Targeted Oncology4h

FDA Issues Warning on BioZorb Markers After Recall Due to Patient Complications

Providers advised to halt use, monitor patients, and report any complications with BioZorb devices to the FDA.

7hon MSN

Hims & Hers stock falls 14% after FDA changes semaglutide supply status (update)

Hims & Hers (HIMS) stock fell 14% following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is no longer ...

5hon MSN

FDA-approved procedure helps regrow knee cartilage, easing pain

Dr. Rick Lehman performs the MACI procedure, which uses the patient's own cells to regrow cartilage in the knee, eliminating ...

oncnursingnews6h

October 2024 FDA Approvals for Oncology

October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...

drugdeliverybusiness10h

FDA approves Abbott CGMs for use during medical imaging

Abbott (NYSE:ABT) announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging ...

Managed Healthcare Executive5h

FDA Accepts Organon’s Application for Prolia Biosimilar

Regulators are also reviewing Teva’s application for its Prolia biosimilar candidate. The FDA’s decisions are expected ...

Central Illinois Proud1h

FDA warns of unlisted steroids in Skin-Cap aerosol cans

The U.S. Food and Drug Administration has warned users of Skin-Cap aerosol spray that there may be undisclosed steroids in ...

Medpage Today on MSN21h

FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD

FDA staff raised familiar safety concerns about sotagliflozin as a treatment for type 1 diabetes (T1D) as the agency again ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results